Remus Pharmaceuticals Revenue

Remus Pharmaceuticals had revenue of 4.00B INR in the half year ending September 30, 2025, with 1,278.06% growth. This brings the company's revenue in the last twelve months to 7.48B, up 63.84% year-over-year. In the fiscal year ending March 31, 2025, Remus Pharmaceuticals had annual revenue of 6.20B with 191.33% growth.

Revenue (ttm)

7.48B

Revenue Growth

+63.84%

P/S Ratio

1.03

Revenue / Employee

109.99M

Employees

Market Cap

7.67B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.20B	4.07B	191.33%
Mar 31, 2024	2.13B	1.68B	371.81%
Mar 31, 2023	451.32M	204.15M	82.59%
Mar 31, 2022	247.17M	59.09M	31.42%
Mar 31, 2021	188.08M	63.89M	51.44%
Mar 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Accent Microcell	2.78B
Infinium Pharmachem	1.57B
Quest Laboratories	1.26B
Sotac Pharmaceuticals	846.72M
Zenith Drugs	1.44B
Vilin Bio Med	199.81M
Medicamen Organics	394.30M
Sunrest Lifescience	520.34M

Revenue Rankings